MAIA Biotechnology Files 8-K
Ticker: MAIA · Form: 8-K · Filed: Dec 20, 2024 · CIK: 1878313
| Field | Detail |
|---|---|
| Company | Maia Biotechnology, INC. (MAIA) |
| Form Type | 8-K |
| Filed Date | Dec 20, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, SEC filing, corporate reporting
TL;DR
MAIA Bio filed an 8-K on Dec 20 for events on Dec 16. Standard reporting.
AI Summary
MAIA Biotechnology, Inc. filed an 8-K on December 20, 2024, reporting events as of December 16, 2024. The filing pertains to "Other Events" and "Financial Statements and Exhibits." The company is incorporated in Delaware and its principal executive offices are located in Chicago, IL.
Why It Matters
This 8-K filing indicates routine corporate reporting, providing updates on significant events and financial disclosures for MAIA Biotechnology, Inc.
Risk Assessment
Risk Level: low — This filing appears to be a routine 8-K for other events and exhibits, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- MAIA Biotechnology, Inc. (company) — Registrant
- December 16, 2024 (date) — Earliest event reported
- December 20, 2024 (date) — Date of report
- Chicago, IL (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for MAIA Biotechnology, Inc.?
The primary purpose of this 8-K filing is to report on "Other Events" and "Financial Statements and Exhibits" as of December 16, 2024.
When was this 8-K report filed with the SEC?
This 8-K report was filed on December 20, 2024.
Where are MAIA Biotechnology, Inc.'s principal executive offices located?
MAIA Biotechnology, Inc.'s principal executive offices are located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.
What is the state of incorporation for MAIA Biotechnology, Inc.?
MAIA Biotechnology, Inc. is incorporated in Delaware.
What is the SEC file number for MAIA Biotechnology, Inc.?
The SEC file number for MAIA Biotechnology, Inc. is 001-41455.
Filing Stats: 781 words · 3 min read · ~3 pages · Grade level 14.1 · Accepted 2024-12-20 13:05:54
Filing Documents
- form8-k.htm (8-K) — 40KB
- ex99-1.htm (EX-99.1) — 16KB
- 0001493152-24-050964.txt ( ) — 236KB
- maia-20241216.xsd (EX-101.SCH) — 3KB
- maia-20241216_lab.xml (EX-101.LAB) — 33KB
- maia-20241216_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: December 20, 2024 MAIA BIOTECHNOLOGY, INC. By: /s/ Vlad Vitoc Name: Vlad Vitoc Title: Chief Executive Officer 3